Neuropsychiatric symptoms and regional neocortical atrophy in mild cognitive impairment and alzheimer's disease

American Journal of Alzheimer's Disease and other Dementias

Volumn 29, Issue 2, 2014, Pages 159-165

  Rafii, Michael S ^a   Taylor, Curtis S ^a   Kim, Hyun T ^a   Desikan, Rahul S ^b   Fleisher, Adam S ^c   Katibian, David ^a   Brewer, James B ^a,b   Dale, Anders M ^a,b   Aisen, Paul S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BANNER ALZHEIMER S INSTITUTE   (United States)

Author keywords

Alzheimer's disease; dementia; neuroimaging; psychosis

Indexed keywords

NEUROLEPTIC AGENT;

AGED; ALZHEIMER DISEASE; ANTERIOR CINGULATE; ARTICLE; BRAIN ATROPHY; CHRONIC DRUG ADMINISTRATION; FEMALE; FRONTAL LOBE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEOCORTEX; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT; PARIETAL LOBE; PSYCHOSIS; SYMPTOM; ATROPHY; COMPLICATION; DISEASE COURSE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PSYCHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATROPHY; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS;

EID: 84898940271     PISSN: 15333175     EISSN: 19382731     Source Type: Journal    
DOI: 10.1177/1533317513507373     Document Type: Article

References (34)

1. Cummings JL The Neuropsychiatry of Alzheimer's Disease and Related Dementias. London: Martin Dunitz ; 2003 :
2. Jeste DV, Finkel SI. Psychosis of Alzheimer's disease and related dementias. diagnostic criteria for a distinct syndrome. Am J Geriatr Psychiatry. 2000 ; 8 (1). 29-34
3. Schneider LS, Dagerman KS. Psychosis of Alzheimer's disease: clinical characteristics and history. J Psychiatr Res. 2004 ; 38 (1). 105-111
4. Paulsen JS, Salmon DP, Thal LJ, et al. Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology. 2000 ; 54 (10). 1965-1971
5. Steele C, Rovner B, Chase GA, Folstein M. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry. 1990 ; 147 (8). 1049-1051
6. Hebert R, Dubois MF, Wolfson C, Chambers L, Cohen C. Factors associated with long-term institutionalization of older people with dementia: data from the Canadian study of health and aging. J Gerontol A Biol Sci Med Sci. 2001 ; 56 (11). M693 - M699
7. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA. 2002 ; 288 (12). 1475-1483
8. Kovacevic S, Rafii MS, Brewer JB. Alzheimer's disease neuroimaging initiative. high-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment. Alzheimer Dis Assoc Disord. 2009 ; 23 (2). 139-145
9. Borgwardt SJ, McGuire PK, Aston J, et al. Reductions in frontal, temporal and parietal volume associated with the onset of psychosis. Schizophr Res. 2008 ; 106 (2-3). 108-114
10. Lagopoulos J, Hermens DF, Naismith SL, Scott EM, Hickie IB. Frontal lobe changes occur early in the course of affective disorders in young people. BMC Psychiatry. 2012 ; 12: 4
11. Whitwell JL, Przybelski SA, Weigand SD, et al. Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: A cluster analysis study. Brain. 2009 ; 132 (pt 11). 2932-2946
12. Grady CL, Haxby JV, Schapiro MB, et al. Subgroups in dementia of the Alzheimer's type identified using positron emission tomography. J Neuropsychiatry Clin Neurosci. 1990 ; 2 (4). 373-384
13. Kotrla KJ, Chacko RC, Harper RG, Jhingran S, Doody R. SPECT findings on psychosis in Alzheimer's disease. Am J Psychiatry. 1995 ; 152 (10). 1470-1475
14. Sultzer DL, Mahler ME, Mandelkern MA, et al. The relationship between psychiatric symptoms and regional neocortical metabolism in Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 1995 ; 7 (4). 476-484
15. Jack CR, Bernstein MA, Fox NC, et al. The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods. J Magn Reson Imaging. 2008 ; 27 (4). 685-691
16. Jovicich J, Czanner S, Greve D, et al. Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage. 2006 ; 30 (2). 436-443
17. Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging. 1998 ; 17 (1). 87-97
18. Dale AM, Fischl B, Sereno MI. Neocortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage. 1999 ; 9 (2). 179-194
19. Fischl B, Sereno MI, Dale AM. Neocortical surface-based analysis. II: inflation, flattening, and a surface-based coordinate system. Neuroimage. 1999 ; 9 (2). 195-207
20. Desikan RS, Ségonne F, Fischl B, et al. An automated labeling system for subdividing the human cerebral neocortex on MRI scans into gyral based regions of interest. Neuroimage. 2006 ; 31 (3). 968-980
21. Holland D, Brewer JB, Hagler DJ, Fennema-Notestine C, Dale AM. Alzheimer's Disease Neuroimaging Initiative. Subregional neuroanatomical change as a biomarker for Alzheimer's disease. Proc Natl Acad Sci USA. 2009 ; 106 (49). 20954-20959
22. Holland D, Dale AM. Alzheimer's Disease Neuroimaging Initiative. Nonlinear registration of longitudinal images and measurement of change in regions of interest. Med Image Anal. 2011 ; 15 (4). 489-497
23. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry. 1984 ; 141 (11). 1356-1364
24. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994 ; 44 (12). 2308-2314
25. Arango C, Rapado-Castro M, Reig S, et al. Progressive brain changes in children and adolescents with first-episode psychosis. Arch Gen Psychiatry. 2012 ; 69 (1). 16-26
26. Fusar-Poli P. Voxel-wise meta-analysis of fMRI studies in patients at clinical high risk for psychosis. J Psychiatry Neurosci. 2012 ; 37 (2). 106-112
27. Mega MS, Lee L, Dinov ID, Mishkin F, Toga AW, Cummings JL. Cerebral correlates of psychotic symptoms in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2000 ; 69 (2). 167-171
28. Devinsky O, Morrell MJ, Vogt BA. Contributions of anterior cingulate neocortex to behaviour. Brain. 1995 ; 118 (pt 1). 279-306
29. Allman JM, Hakeem A, Erwin JM, Nimchinsky E, Hof P. The anterior cingulate neocortex. The evolution of an in-terface between emotion and cognition. Ann N Y Acad Sci. 2001 ; 935: 107-117
30. Zamboni G, Huey ED, Krueger F, Nichelli PF, Grafman J. Apathy and disinhibition in frontotemporal dementia: insights into their neural correlates. Neurology. 2008 ; 71 (10). 736-742
31. Chui HC, Lyness SA, Sobel E, Schneider LS. Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease. Arc Neurol. 1994 ; 51 (7). 676-681
32. Stern Y, Albert M, Brandt J, et al. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the predictors study. Neurology. 1994 ; 44 (12). 2300-2307
33. Grundman M, Petersen RC, Ferris SH, et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004 ; 61 (1). 59-66
34. Apostolova LG, Cummings JL. Neuropsychiatric manifestations in mild cognitive impairment: A systematic review of the literature. Dement Geriatr Cogn Disord. 2008 ; 25 (2). 115-126